위장관 출혈 치료 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Gastrointestinal Bleeding Treatment Market size is expected to reach USD 1.93 Billion in 2034 from USD 0.96 Billion (2025) growing at a CAGR of 8.06% during 2026-2034.

The gastrointestinal bleeding treatment market is witnessing growth due to the increasing incidence of gastrointestinal disorders, ulcers, and colorectal cancers. Aging populations and unhealthy lifestyles, including excessive alcohol consumption and poor dietary habits, are contributing to higher prevalence rates. Advances in diagnostic techniques are enabling early detection, thereby boosting demand for effective treatment solutions.

Key drivers include the adoption of minimally invasive endoscopic procedures, improved hemostatic devices, and expanding healthcare infrastructure in developing regions. Pharmaceutical therapies, blood transfusion services, and advanced surgical techniques are enhancing treatment outcomes. Growing awareness and improved emergency care services are further supporting market expansion globally.

Future growth will be driven by innovations in endoscopic therapies and targeted drug development. Increased healthcare spending and insurance coverage are expected to improve patient access to treatment. As medical technologies evolve and patient outcomes improve, the gastrointestinal bleeding treatment market is anticipated to maintain steady long-term growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Endoscopic Hemostatic Devices
• Endoscopic Mechanical Devices
• Endoscopic Thermal Devices
• Closure Devices
• Other

By GI Tract Division

• Upper GI tract
• Lower GI tract

By Onset

• Acute
• Chronic

By End-use

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Other

COMPANIES PROFILED

• Boston Scientific Corporation, Conmed Corporation, Cook Group, ERBE Elektromedizin GmbH, Medtronic PLC, Olympus Corporation, Ovesco Endoscopy AG, Pfizer Inc, STERIS PLC, US Medical Innovations
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Endoscopic Hemostatic Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Endoscopic Mechanical Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Endoscopic Thermal Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Closure Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT MARKET: BY GI TRACT DIVISION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Gi Tract Division
• 5.2. Upper GI tract Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Lower GI tract Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT MARKET: BY ONSET 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Onset
• 6.2. Acute Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Chronic Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT MARKET: BY END-USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-use
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Ambulatory Surgical Centers (ASCs) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Gi Tract Division
  • 8.2.3 By Onset
  • 8.2.4 By End-use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Gi Tract Division
  • 8.3.3 By Onset
  • 8.3.4 By End-use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Gi Tract Division
  • 8.4.3 By Onset
  • 8.4.4 By End-use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Gi Tract Division
  • 8.5.3 By Onset
  • 8.5.4 By End-use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Gi Tract Division
  • 8.6.3 By Onset
  • 8.6.4 By End-use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL GASTROINTESTINAL BLEEDING TREATMENT INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Boston Scientific Corporation
  • 10.2.2 Conmed Corporation
  • 10.2.3 Cook Group
  • 10.2.4 ERBE Elektromedizin GmbH
  • 10.2.5 Medtronic PLC
  • 10.2.6 Olympus Corporation
  • 10.2.7 Ovesco Endoscopy AG
  • 10.2.8 Pfizer Inc
  • 10.2.9 STERIS PLC
  • 10.2.10 US Medical Innovations